We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$97.2B
AUM Growth
-$1.3B
Cap. Flow
-$5.03B
Cap. Flow %
-5.17%
Top 10 Hldgs %
14.17%
Holding
3,859
New
105
Increased
2,176
Reduced
995
Closed
137

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$406M
2
PG icon
Procter & Gamble
PG
+$287M
3
MSFT icon
Microsoft
MSFT
+$245M
4
GLD icon
SPDR Gold Trust
GLD
+$200M
5
ORCL icon
Oracle
ORCL
+$180M

Sector Composition

Rank Sector Weight
1 Healthcare 17.37%
2 Financials 15.48%
3 Technology 10.61%
4 Energy 8.14%
5 Industrials 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICBK
3301
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$39K ﹤0.01%
1,930
+707
+58% +$14.6K
CVRS
3302
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$39K ﹤0.01%
34,998
+10,554
+43% +$14.1K
PCMI
3303
DELISTED
PCM, Inc
PCMI
$39K ﹤0.01%
1,806
+290
+19% +$4.73K
HAPN
3304
CALL
Happen Inc
HAPN
$2.21B
$38K ﹤0.01%
1,240
+260
+27% +$6.75K
NGVC icon
3305
Vitamin Cottage Natural Grocers
NGVC
$739M
$38K ﹤0.01%
3,384
+810
+31% +$10K
PLPC icon
3306
Preformed Line Products
PLPC
$1.75B
$38K ﹤0.01%
899
+269
+43% +$11.6K
PAMT
3307
PAMT Corp
PAMT
$337M
$38K ﹤0.01%
7,496
SYUT
3308
DELISTED
Synutra International, Inc.
SYUT
$37K ﹤0.01%
8,669
+2,859
+49% +$10.8K
RXII
3309
DELISTED
GALENA BIOPHARMA INC COM
RXII
$37K ﹤0.01%
106,061
+21,790
+26% +$7.6K
AST
3310
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$37K ﹤0.01%
8,759
+2,621
+43% +$8.48K
DMTX
3311
DELISTED
Dimension Therapeutics, Inc
DMTX
$37K ﹤0.01%
4,685
+1,393
+42% +$10.1K
KONA
3312
DELISTED
Kona Grill, Inc.
KONA
$36K ﹤0.01%
2,900
AXSM icon
3313
Axsome Therapeutics
AXSM
$11.2B
$35K ﹤0.01%
4,402
+1,558
+55% +$11.8K
NDLS icon
3314
Noodles & Co
NDLS
$111M
$35K ﹤0.01%
928
DALN
3315
DELISTED
DallasNews
DALN
$34K ﹤0.01%
1,153
+253
+28% +$6K
MLP icon
3316
Maui Land & Pineapple Co
MLP
$344M
$34K ﹤0.01%
5,106
UBCP icon
3317
United Bancorp
UBCP
$90.7M
$34K ﹤0.01%
3,115
VNRX icon
3318
VolitionRx Ltd
VNRX
$8.65M
$34K ﹤0.01%
320
+249
+351% +$19.3K
AVGR
3319
DELISTED
Avinger, Inc. Common Stock
AVGR
0
INDT
3320
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$34K ﹤0.01%
1,073
ACHV icon
3321
Achieve Life Sciences
ACHV
$659M
$33K ﹤0.01%
30
-25
-45% -$39.9K
ADX icon
3322
Adams Diversified Equity Fund
ADX
$3.13B
$33K ﹤0.01%
+2,485
New +$32.5K
CHMI
3323
Cherry Hill Mortgage Investment Corp
CHMI
$83M
$33K ﹤0.01%
1,917
+90
+5% +$1.45K
FLNT
3324
Fluent
FLNT
$102M
$33K ﹤0.01%
1,084
+396
+58% +$12.1K
GDX icon
3325
VanEck Gold Miners ETF
GDX
$22.7B
$33K ﹤0.01%
1,265
-4,435
-78% -$127K

Similar funds

BlackRock Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, BlackRock Advisors held 3,859 positions worth $97.2B, down 1.3% from $98.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors withdrew a net $5.03B in Q3 2016, closing 137 positions and reducing 995 holdings. Its most notable exit was EMC CORPORATION, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

Against the trend, BlackRock Advisors opened a new position in State Street Financial Select Sector SPDR ETF worth $180M.

  • BlackRock Advisors's largest Q3 2016 buy was State Street Financial Select Sector SPDR ETF: 9,343,498 shares worth $180M.
  • BlackRock Advisors added most to State Street SPDR Bloomberg High Yield Bond ETF in Q3 2016, an estimated $281M increase.
  • BlackRock Advisors's biggest Q3 2016 reduction was Intel, cutting an estimated $406M.
  • BlackRock Advisors fully exited EMC CORPORATION in Q3 2016, selling an estimated $106M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $97.2B portfolio in Q3 2016.
  • BlackRock Advisors opened 105 new positions and closed 137 in Q3 2016.
  • BlackRock Advisors's portfolio value fell 1.3% quarter-over-quarter to $97.2B.

Based on BlackRock Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.